On 2026-08-13, Pelthos Therapeutics Inc. (PTHS) announced earnings per share of $-6.62 for the fiscal quarter ending 2026-06-30, missing the average analyst estimate of $-3.02.
The next expected annoucement date for quarterly earnings is 2026-11-12, with an average estimated earnings per share of $-2.83 for the fiscal quarter ending 2026-09-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2026-08-13 | 2026-06-30 | $-3.02 | $-6.62 |
| 2026-05-14 | 2026-03-31 | $-4.00 | $-3.09 |
| 2026-03-19 | 2025-12-31 | $-3.95 | $-2.83 |
| 2025-11-13 | 2025-09-30 | $-0.67 | $-5.30 |
| 2025-08-13 | 2025-06-30 | -- | $-5.38 |
| 2025-05-13 | 2025-03-31 | -- | $-3.20 |
| 2025-03-27 | 2024-12-31 | -- | $-3.20 |
| 2024-11-13 | 2024-09-30 | -- | $-2.90 |
| 2024-08-13 | 2024-06-30 | -- | $-3.10 |
| 2024-05-15 | 2024-03-31 | -- | $-5.50 |